We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
MiroMatrix Medical Inc | NASDAQ:MIRO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.39 | 3.50 | 3.67 | 0 | 01:00:00 |
M. Mason Macenski, Ph.D, Vice President Clinical and Regulatory Affairs, will be presenting on behalf of Miromatrix on Thursday, October 19 from 2:00pm – 3:00pm PDT. The presentation is titled Maximizing the gift of life: Using perfusion technology to bioengineer multiple transplantable kidneys from a single donor kidney.
The ISODP congresses are held every other year in numerous geographic regions of the world to highlight organ donation and transplantation with the intent to share best practices and improve organ donation for that country.
About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.
Investor Contact Greg Chodaczek ir@miromatrix.com Media Contact: Christina Campbell 612-924-3793 Christina@media-minefield.com
1 Year MiroMatrix Medical Chart |
1 Month MiroMatrix Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions